Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dietary Supplement GMP Warning Letters

This article was originally published in The Tan Sheet

Executive Summary

NYSW Beverage Brands responds to FDA that some ingredients are provided with specification sheets from suppliers. The agency advises the firm is “still responsible for establishing specifications” and that “reliance on the specification sheets provided by your supplier is insufficient to meet” GMP requirements.

You may also be interested in...



Dietary Ingredient Identity Testing Exemptions Remain A Puzzle

The trade groups ask FDA to keep open the door for supplement firms to petition for 100% identity testing exemptions under an IFR published in 2007. AHPA and NPA say supplement manufacturers have insufficient guidance on information the agency expects in petitions for identity testing waivers.

Supplier Qualification Guideline Touts Flexibility, Defers Best Practices

The Standardized Information on Dietary Ingredients Work Group publishes a guide to help supplement firms qualify ingredient suppliers under FDA good manufacturing practices. But with only three out of five major industry associations involved, not everyone is on board with the SIDI efforts.

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel